We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First Genomic Research Studies Published Utilizing Collaborative Cross Mice

By LabMedica International staff writers
Posted on 04 Aug 2011
Print article
The Collaborative Cross (CC) represents a large collection of new inbred mouse strains created by the mouse genetics community aimed at transforming the study of complex genetic traits and diseases. Derived from classical inbred strains and wild-derived strains, the CC captures nearly 90% of known genetic variation in laboratory mice, far exceeding more commonly used inbred strains.

The CC is a tool to integrate studies of gene function and gene networks, allowing the prediction and testing of biologic models based on the whole organism, vital to the development of customized therapies for humans. The journal Genome Research has published three articles online utilizing strains from the emerging Collaborative Cross mouse strains.

The first study concerns Collaborative Cross strains facilitate mapping of causative loci; In this work, published in the April 2011 issue of Genome Research, Dr. Katherine I. Fisher-Aylor and colleagues from the California Institute of Technology (Caltech; Pasadena, USA), Systemix Institute (Redmond, WA, USA), and the Lawrence Berkeley National Laboratory (Berkeley, CA, USA) performed an experiment called the pre-CC study, the first genetic data and analysis from the emerging strains of the CC. Their research revealed that the genomes of CC strains are genetically diverse and contain balanced contributions from each founding strain.

Highlighting the statistical power provided by the CC, Dr. Aylor and colleagues utilized ancestry data of the CC strains to map genetic loci for a Mendelian trait (white head-spotting), a complex trait (body weight), and a molecular trait (gene expression in the liver), demonstrating the ancestry-based approach to be superior to established marker-based methods for trait loci discovery.

The development of the Collaborative Cross presents a unique opportunity to investigate how the breeding of inbred strains affects genetic structure and the diversity of phenotypes. In another article, published online July 6, 2011, Dr. Vivek M. Philip and colleagues from the Systems Genetics Group, biosciences division, Oak Ridge National Laboratory (Oak Ridge, TN, USA) and the University of Tennessee (Knoxville, TN, USA) have evaluated the range of many traits in late inbreeding populations of the CC, including such phenotypes as body weight, tail length, heart weight, and behavioral traits. In spite of the influence of breeding selection in the CC lines, detection of major genetic loci regulating trait variation remained possible. This analysis revealed the scope of phenotypic variation that will be present in the finished strains of the CC.

Aspergillosis is a serious disease in humans, particularly in immune-compromised individuals, caused by infection with the fungus Aspergillus. The mouse has been an important model for studying Aspergillus infection, but classical laboratory strains of mice used in these studies arose from a small set of founders and lack most of the genetic variation present in wild mice, limiting researchers’ ability to identify additional genetic loci relevant to disease.

In the last study, published online April 14, 2011, issue of Genome Research, Dr. Caroline Durrant, from Wellcome Trust Center for Human Genetics, University of Oxford, UK), and colleagues from the department of clinical microbiology and immunology, Sackler Faculty of Medicine, Tel Aviv University (Tel Aviv, Israel), and the department of genetics, University of North Carolina (Chapel Hill, NC, USA) utilized inbred mouse strains from the Collaborative Cross, exploiting the genetic contribution of wild-derived strains, to identify novel loci that confer susceptibility to infection with the fungus Aspergillus.

By integrating genetic variation data from the genomes of the founding strains of the CC, Dr. Durrant and colleagues additionally modified the genetic loci associated with Aspergillus susceptibility to suggest specific candidate genes.

Related Links:
California Institute of Technology
Ridge National Laboratory
Wellcome Trust Center for Human Genetics



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
Silver Member
Static Concentrator
BJP 10

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.